Close
Smart Skin Technologies
Thermofisher
News

Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Business & Industry

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...
Business & Industry

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...
News

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
- Advertisement -
Xylem

Alexion Pharmaceuticals, Inc announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday, May 10, 2016 at 10:40 a.m., Pacific Time.

An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexionpharm.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

 

Contact:

Alexion Pharmaceuticals, Inc.
Elena Ridloff, CFA
Vice President, Investor Relations
(203) 699-7722

 

Xylem

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector
Subscribe for Free

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Previous article
AbbVie to Acquisition of Stemcentrx and its Novel
Next article
Baxter Announces Appointment of Interim President for Its Renal Business

Related stories

Business & Industry

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...
Business & Industry

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...
News

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
BioPharma

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee...